Assi, R., Kantarjian, H. M., Garcia‐Manero, G., Cortes, J. E., Pemmaraju, N., Wang, X., Nogueras‐Gonzalez, G., Jabbour, E., Bose, P., Kadia, T., Dinardo, C. D., Patel, K., Bueso‐Ramos, C., Zhou, L., Pierce, S., Gergis, R., Tuttle, C., Borthakur, G., Estrov, Z., Luthra, R., Hidalgo‐Lopez, J., Verstovsek, S., & Daver, N. (n.d.). a phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. American journal of hematology, 93(2), 277–285. http://access.bl.uk/ark:/81055/vdc_100055538704.0x000045